Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
De Novo Foodlabs is a precision fermentation company specializing in the production of high-value, animal-free proteins. Originally founded as De Novo Dairy, the company utilizes proprietary yeast strains to create nature-identical dairy proteins, such as lactoferrin, without the need for traditional animal farming. Their technology aims to provide sustainable, ethical, and functional alternatives for the infant formula, sports nutrition, and health supplement markets. By decoupling protein production from the environmental footprint of cattle, De Novo Foodlabs addresses global food security and sustainability challenges. The company is currently focused on scaling its production processes and navigating regulatory pathways for commercial launch.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on De Novo Foodlabs.